Live Breaking News & Updates on Juan Camilo Arjona

Stay updated with breaking news from Juan camilo arjona. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Myovant Sciences Ltd. (MYOV) Q1 2021 Earnings Call Transcript


Operator
Good day, everyone, and welcome to Myovant Sciences first-quarter of fiscal year 2021 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Please go ahead.
Ryan Crowe
Vice President of Investor Relations
Thank you, operator. Good morning and thanks for joining us today to review the financial results of Myovant s first quarter of fiscal year 2021 and to discuss other corporate and business updates. Joining me for today s call are Dave Marek, Myovant s chief executive officer; Frank Karbe, president and chief financial officer; Lauren Merendino, chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer. ....

Sumitomo Dainippon Pharma , Lauren Merendino , Phil Nadeau Cowen , Josh Schimmer , Jason Butler , Bryan Crowe , Frank Karbe , Juan Camilo , Paul Choi Goldman Sachs , Juan Camilo Arjona , Brian Skorney , Paul Choi , Dave Marek , Phil Nadeau , Deric Joseph , Brian Skorney Baird , Myovant Sciences Ltd , Myovant Sciences , European Commission , Goldman Sachs , Company Analyst , Gedeon Richter , Investor Relations , Withdrawal Study , Liberty Clinical Trial , Liberty Clinical ,

Myovant Sciences Ltd. (MYOV) Q3 2020 Earnings Call Transcript


Operator
Good day, everyone, and welcome to Myovant Sciences third quarter of fiscal-year 2020 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Please go ahead.
Ryan Crowe
Vice President, Investor Relations
Thank you, operator. Good morning, and thanks for joining us today for a general business update and to review the financial results of Myovant s third quarter of fiscal-year 2020. Joining me for today s call are Dave Marek, Myovant s chief executive officer, Frank Karbe, president and chief financial officer; Adele Gulfo, interim chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer. ....

United States , Frank Karbe , Adele Gulfo , Bryan Crowe , Dave Marek , Juan Camilo , Juan Camilo Arjona , Myovant Sciences Ltd , Myovant Sciences , Investor Relations , Adding Pfizer , ஒன்றுபட்டது மாநிலங்களில் , ரியான் காகம் , டேவ் மரேக் , ஜுவான் கேமிலோ , முதலீட்டாளர் உறவுகள் ,